ELOX logo

Eloxx Pharmaceuticals (ELOX) Shareholders Equity

Annual Shareholders Equity

-$10.66 M
-$33.04 M-147.62%

December 31, 2022


Summary


Performance

ELOX Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELOXbalance sheetmetrics:

Quarterly Shareholders Equity

-$20.05 M
-$1.45 M-7.81%

September 30, 2023


Summary


Performance

ELOX Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELOXbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

ELOX Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-147.6%-302.4%
3 y3 years-129.4%-233.0%
5 y5 years-149.9%-146.7%

ELOX Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-147.6%at low-189.6%at low
5 y5-year-129.4%at low-149.3%at low
alltimeall time-124.8%at low-133.5%at low

Eloxx Pharmaceuticals Shareholders Equity History

DateAnnualQuarterly
Sep 2023
-
-$20.05 M(+7.8%)
Jun 2023
-
-$18.60 M(+14.1%)
Mar 2023
-
-$16.29 M(+52.8%)
Dec 2022
-$10.66 M(-147.6%)
-$10.66 M(+114.0%)
Sep 2022
-
-$4.98 M(-374.9%)
Jun 2022
-
$1.81 M(-84.5%)
Mar 2022
-
$11.69 M(-47.8%)
Dec 2021
$22.38 M(+118.8%)
$22.38 M(-32.2%)
Sep 2021
-
$33.00 M(-18.8%)
Jun 2021
-
$40.64 M(+1377.9%)
Mar 2021
-
$2.75 M(-73.1%)
Dec 2020
$10.23 M(-71.8%)
$10.23 M(-32.2%)
Sep 2020
-
$15.08 M(-25.7%)
Jun 2020
-
$20.29 M(-22.7%)
Mar 2020
-
$26.26 M(-27.5%)
Dec 2019
$36.21 M(-15.6%)
$36.21 M(-19.9%)
Sep 2019
-
$45.23 M(-18.1%)
Jun 2019
-
$55.22 M(+60.4%)
Mar 2019
-
$34.43 M(-19.8%)
Dec 2018
$42.91 M(+100.9%)
$42.91 M(-16.6%)
Sep 2018
-
$51.46 M(-14.1%)
Jun 2018
-
$59.92 M(+343.7%)
Mar 2018
-
$13.50 M(+307.4%)
Dec 2017
$21.36 M(+2351.9%)
-
Sep 2017
-
$3.31 M(+280.5%)
Jun 2017
-
$871.20 K(-66.3%)
Jun 2017
$871.20 K(-80.9%)
-
Mar 2017
-
$2.58 M(-9.1%)
Dec 2016
-
$2.84 M(-21.6%)
Sep 2016
-
$3.63 M(-20.5%)
Jun 2016
$4.56 M(-62.7%)
$4.56 M(-19.2%)
Mar 2016
-
$5.64 M(-35.3%)
Dec 2015
-
$8.72 M(-30.2%)
Sep 2015
-
$12.51 M(+2.3%)
Jun 2015
$12.22 M(-55.5%)
$12.22 M(+9.1%)
Mar 2015
-
$11.21 M(-6.1%)
Dec 2014
-
$11.94 M(-46.8%)
Sep 2014
-
$22.43 M(-18.4%)
Jun 2014
$27.49 M(+626.1%)
$27.49 M(+180.4%)
Mar 2014
-
$9.80 M(+27.0%)
Dec 2013
-
$7.72 M(+264.6%)
Sep 2013
-
$2.12 M(-44.1%)
Jun 2013
$3.79 M(+9.6%)
$3.79 M(+14.3%)
Mar 2013
-
$3.31 M(+109.5%)
Dec 2012
-
$1.58 M(-39.9%)
Sep 2012
-
$2.63 M(-23.9%)
Jun 2012
$3.45 M(-23.6%)
$3.45 M(-24.9%)
Mar 2012
-
$4.60 M(+62.3%)
Dec 2011
-
$2.83 M(-28.0%)
Sep 2011
-
$3.93 M(-12.9%)
DateAnnualQuarterly
Jun 2011
$4.52 M(-43.4%)
$4.52 M(-34.5%)
Mar 2011
-
$6.90 M(+2.7%)
Dec 2010
-
$6.72 M(-6.8%)
Sep 2010
-
$7.21 M(-9.7%)
Jun 2010
$7.98 M(+40.8%)
$7.98 M(+4297.2%)
Mar 2010
-
$181.50 K(-95.7%)
Dec 2009
-
$4.22 M(-10.3%)
Sep 2009
-
$4.70 M(-17.1%)
Jun 2009
$5.67 M(-42.4%)
$5.67 M(-17.3%)
Mar 2009
-
$6.86 M(-12.3%)
Dec 2008
-
$7.82 M(-13.1%)
Sep 2008
-
$8.99 M(-8.5%)
Jun 2008
$9.84 M(+265.7%)
$9.84 M(+45.5%)
Mar 2008
-
$6.76 M(-15.9%)
Dec 2007
-
$8.04 M(+108.5%)
Sep 2007
-
$3.86 M(+43.4%)
Jun 2007
$2.69 M(-8.9%)
$2.69 M(-19.5%)
Mar 2007
-
$3.34 M(-18.1%)
Dec 2006
-
$4.08 M(+67.4%)
Sep 2006
-
$2.44 M(-17.4%)
Jun 2006
$2.95 M(-47.2%)
$2.95 M(-19.1%)
Mar 2006
-
$3.65 M(-14.4%)
Dec 2005
-
$4.26 M(-13.6%)
Sep 2005
-
$4.93 M(-11.7%)
Jun 2005
$5.59 M(+18.2%)
$5.59 M(+71.5%)
Mar 2005
-
$3.26 M(-15.7%)
Dec 2004
-
$3.87 M(-7.5%)
Sep 2004
-
$4.18 M(-11.6%)
Jun 2004
$4.73 M(+65.6%)
$4.73 M(-2.2%)
Mar 2004
-
$4.84 M(+149.3%)
Dec 2003
-
$1.94 M(-15.6%)
Sep 2003
-
$2.30 M(-19.5%)
Jun 2003
$2.86 M(-40.3%)
$2.86 M(-14.2%)
Mar 2003
-
$3.33 M(-13.4%)
Dec 2002
-
$3.85 M(-10.8%)
Sep 2002
-
$4.31 M(-9.9%)
Jun 2002
$4.79 M(-2415.3%)
$4.79 M(+34.8%)
Mar 2002
-
$3.55 M(+34.2%)
Dec 2001
-
$2.64 M(-577.2%)
Sep 2001
-
-$554.10 K(+168.1%)
Jun 2001
-$206.70 K(-113.6%)
-$206.70 K(-199.5%)
Mar 2001
-
$207.70 K(-66.3%)
Dec 2000
-
$616.20 K(-43.1%)
Sep 2000
-
$1.08 M(-28.7%)
Jun 2000
$1.52 M(+66.5%)
$1.52 M(+8383.8%)
Mar 2000
-
$17.90 K(-82.1%)
Dec 1999
-
$100.00 K
Jun 1999
$912.20 K(<-9900.0%)
-
Jun 1998
-$3100.00(-11.4%)
-
Jun 1997
-$3500.00
-

FAQ

  • What is Eloxx Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for Eloxx Pharmaceuticals?
  • What is Eloxx Pharmaceuticals annual shareholders equity year-on-year change?
  • What is Eloxx Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Eloxx Pharmaceuticals?
  • What is Eloxx Pharmaceuticals quarterly shareholders equity year-on-year change?

What is Eloxx Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of ELOX is -$10.66 M

What is the all time high annual shareholders equity for Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals all-time high annual stockholders equity is $42.91 M

What is Eloxx Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, ELOX annual stockholders equity has changed by -$33.04 M (-147.62%)

What is Eloxx Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of ELOX is -$20.05 M

What is the all time high quarterly shareholders equity for Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals all-time high quarterly stockholders equity is $59.92 M

What is Eloxx Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, ELOX quarterly stockholders equity has changed by -$15.07 M (-302.41%)